Expression of CSF-1 and CSF-1 receptor by normal lactating mammary epithelial cells

Journal of the Society for Gynecologic Investigation

Volumn 5, Issue 2, 1998, Pages 94-101

  Sapi, Eva ^a   Flick, Maryann B ^a   Rodov D, Sofya ^a   Carter, Daryl ^a   Kacinski, Barry M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; c fms; Lactogenesis; Organ culture; Prolactin; RU 486

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; GLUCOCORTICOID; INSULIN; MESSENGER RNA; PROLACTIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACTATION; MILK PRODUCTION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTO ONCOGENE; RNA ANALYSIS; ANIMAL; BAGG ALBINO MOUSE; BREAST; BREAST TUMOR; CELL CULTURE; CELL LINE; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE; ORGAN CULTURE TECHNIQUE; PREGNANCY; UDDER;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL LINE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; INSULIN; LACTATION; MACROPHAGE COLONY-STIMULATING FACTOR; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; ORGAN CULTURE TECHNIQUES; PREGNANCY; PROLACTIN; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032008524     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(97)00108-1     Document Type: Article

References (38)

1. 1. Heisterkamp N, Groffen J, Stephenson JR. Isolation of v-fms and its human cellular homolog. Virology 1983;126:248-58.
2. 2. Rettenmeier CW, Chen JH, Roussel MF, Sherr CJ. The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity. Science 1985;228:320-2.
3. 3. Sherr CJ. The fms oncogene. Biochim Biophys Acta 1988;948: 225-43.
4. 4. Woolford JV, Rothwell V, Rohrschneider LR. Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage. Mol Cell Biol 1985;5:3458-66.
5. 5. Sariban E, Mitchell T, Kufe D. Expression of the c-fms proto-oncogene during human monocytic differentiation. Nature 1985;316:64-6.
6. 6. Pollard JW, Bartocci A, Arceci R, Orlovsky A, Ladner MB, Stanley ER. Apparent role of the macrophage growth factor CSF-1 in placental development. Nature 1987;330:484-6.
7. 7. Daiter E, Pampfer S, Yeung YG, Barad D, Stanley ER, Pollard JW. Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metabol 1992;74:850-8.
8. 8. Kacinski BM, Scata KA, Carter D, et al. FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 1991;6:941-52.
9. 9. Tang RP, Beuvon F, Ojeda M, Mosseri V, Pouillart P, Scholl S. M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells. M-CSF mediated recruitment of tumour infiltrating monocytes. J Cell Biochem 1992;50: 350-6.
10. 10. Hara T, Irie K, Saito S, et al. Identification of macrophage colony-stimulating factor in human milk and mammary gland epithelial cells. Pediatr Res 1995;37:437-43.
11. 11. Pollard JW, Henninghausen L. Colony-stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci USA 1994;91:9312-6.
12. 12. Ramakrishnan S, Xu FJ, Brandt SJ, Niedel JE, Bast RC, Brown EL. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest 1989;83:921-6.
13. 13. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurrock R. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 1991; 67:990-6.
14. 14. Flick MB, Sapi E, Perotta PL, et al. Recognition of activated CSF-1 receptor in breast carcinomas by tyrosme 723 phosphospecific antibody. Oncogene 1997;14:2553-61.
15. 15. Scholl SM, Crocker P, Tarig R, Pouillart P, Pollard JW. Is colony-stimulating factor-1 a key mediator of breast cancer invasion and metastasis. Mol Carcinog 1993;7:207-11.
16. 16. Kacinski BM, Carter D, Mittal K, et al. Ovarian adenocarcinomas express fms-complementary transcripts and fins antigen, often with co-expression of CSF-1. Am J Pathol 1990;137:135-47.
17. 17. Kacinski BM, Carter D, Mittal K, et al. High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. Int J Radiat Oncol Biol Phys 1988;15:823-9.
18. 18. Bartocci A, Pollard JW, Stanley ER. Regulation of colony stimulating factor-1 during pregnancy. J Exp Med 1986;164:956-61.
19. 19. Sapi E, Flick MB, Gilmore-Hebert M, Rodov S, Kacinski BM. Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids. Oncogene 1995;10:529-42.
20. 20. Topper YJ, Freeman TCS. Multiple hormone interactions in the development biology of the mammary gland. Physiol Rev 1980; 60:1049-94.
21. 21. Hynes NE, Taverna D, Harwetz IM, et al. Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the β-casein gene in mouse mammary epithelial cells. Mol Cell Biol 1990;10:4027-34.
22. 22. Stanley ER. The macrophage colony stimulating factor CSF-1. In: Colwick SP, Kaplan NO, eds. Methods in enzymology. San Diego: Academic Press, 1985;564-87.
23. 23. Coussens L, Van Beveren C, Smith D, et al. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 1986;320:277-80.
24. 24. Yoshimura M, Banerjee MR, Oka T. Nucleotide sequence of a cDNA encoding mouse β-casein. Nucleic Acids Res 1986;14: 8224.
25. 25. Full G, Wells JA. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J Biol Chem 1995;270:13133-7.
26. 26. Cappeletti V, Ruedl C, Miodini P, et al. Paracrine interaction in co-culture of hormone dependent and independent breast cancer cells. Breast Cancer Res Treat 1993;26:275-81.
27. 27. Bussman LE, Bussman EM, Charreau EH. Role of receptors for epidermal growth factor and insulin-like growth factors I and II in the differentiation of rat mammary glands from lactogenesis I to lactogenesis II. J Reprod Fertil 1996;107:307-14.
28. 28. Sapi E, Flick MB, Rodov S. et al. Independent regulation of invasion and anchorage-independent growth by different auto-phosphorylation sites of the macrophage colony-stimulating factor 1 receptor. Cancer Res 1996;56:5704-12.
29. 29. Filderman A, Bruckner A, Kacinski BM, Deng M, Hines G, Remold H. Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor (CSF-1)-positive cancer cell lines. Cancer Res 1992;52:3661-9.
30. 30. Ossowski L, Biegel D, Reich E. Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 1979;16: 929-40.
31. 31. Talkhoud RS, Chin JR, Unemon EN, Werb Z, Bissell MJ. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 1991;112: 439-49.
32. 32. Eichfeld U, Haerting J, Schwanz I. Serum prolactin levels of primary breast cancer. Tumordiagnostik Therapie 1993;14:194-200.
33. 33. Wang DY, Stepniewska KA, Allen DS, et al. Serum prolactin levels and their relationship to survival in women with operable breast cancer. J Clin Epidemiol 1995;48:959-68.
34. 34. Patel DD, Bhatavdekar JM, Chikhlikar PR, et al. Node negative breast carcinoma - hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators. J Surg Oncol 1996;62:86-92.
35. 35. Wiznitzer I, Benz C. Direct growth-inhibiting effects of the prolactm antagonists burserelin and pergohde on human breast cancer. Proc Am Assoc Cancer Res 1984;25:208.
36. 36. Biswas R, Vonderhaar BK. Tamoxifen inhibition of prolactin action in the mouse mammary gland. Endocrinology 1991;128: 532-8.
37. 37. Klijn JGM, dejong FH, Bakker GH, Lamberts SWJ, Rodenburg CJ, Alexieva-Figush J. Antiprogestins, a new form of endocrine therapy for human breast cancer. Cancer Res 1989;49:2851-6.
38. 38. Maudelonde T, Romieu G, Ulmann A, et al. First clinical trial of the use of the antiprogestin RU486 in advanced breast cancer. Hormonal manipulation of cancer: peptides, growth factors, and new (anti)steroidal agents. New York: Raven Press, 1987.